OmniAb (OABI) Operating Margin (2022 - 2026)

OmniAb's (OABI) quarterly Operating Margin came in at 54.27% in Q1 2026, up 39937.0% year-on-year from N/an in Q1 2025, and up 71.17% on a QoQ basis from 188.23% in Q4 2025.

OmniAb (OABI) Operating Margin (2022 - 2026) Analysis & Trends

OmniAb (OABI) has 5 years of Operating Margin data on file, last reported at 54.27% in Q1 2026.

  • On a quarterly basis, Operating Margin rose 39937.0% year-over-year to 54.27% in Q1 2026; TTM through Mar 2026 was 200.26%, a 6444.0% increase from a year earlier, with the FY2025 full-year figure at 369.49%, down 8719.0% from the prior year.
  • Operating Margin for Q1 2026 stood at 54.27%, up from 188.23% in the prior quarter.
  • Over the last five years, Operating Margin for OABI reached as high as 25.6% in Q4 2022 and fell as low as 810.18% in Q3 2025.
  • Historically, Operating Margin has averaged 290.67% across 5 years, with a median of 215.76% in 2022.
  • Across the five-year window, Operating Margin sank 54338 bps in 2024 and soared 39937 bps in 2026, its largest moves.
  • Year by year, Operating Margin stood at 25.6% in 2022, then slumped by 1818 bps to 439.78% in 2023, then soared by 67 bps to 146.98% in 2024, then declined by 28 bps to 188.23% in 2025, then jumped by 71 bps to 54.27% in 2026.
  • Per Business Quant data, the three most recent Operating Margin figures were 54.27% in Q1 2026, 188.23% in Q4 2025, and 810.18% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 16.51%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 17.83%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 31.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 OmniAb 261.62 Mn 212.55 Mn 14.41 Mn -54.27%

Historic Data

Download Data
DateValue
Mar 31, 2026 -54.27%
Dec 31, 2025 -188.23%
Sep 30, 2025 -810.18%
Jun 30, 2025 -416.19%
Mar 31, 2025 -453.64%
Dec 31, 2024 -146.98%
Sep 30, 2024 -473.73%
Jun 30, 2024 -214.14%
Mar 31, 2024 -593.34%
Dec 31, 2023 -439.78%
Sep 30, 2023 -370.91%
Jun 30, 2023 -279.95%
Mar 31, 2023 -49.96%
Dec 31, 2022 25.60%
Sep 30, 2022 -215.76%
Jun 30, 2022 -174.55%
Mar 31, 2022 -85.45%